Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcutis Biotherapeutics Inc
(NQ:
ARQT
)
9.205
-0.145 (-1.55%)
Streaming Delayed Price
Updated: 12:31 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arcutis Biotherapeutics Inc
< Previous
1
2
3
4
Next >
DraftKings To Rally Over 48%? Here Are 10 Top Analyst Forecasts For Monday
November 06, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 03, 2023
Via
Benzinga
Top 5 Health Care Stocks That Are Preparing To Pump In November
November 03, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Earnings Outlook For Arcutis Biotherapeutics
November 02, 2023
Via
Benzinga
MSP Recovery And 3 Other Stocks Under $3 Insiders Are Buying
October 27, 2023
The Dow Jones closed lower by over 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations for Arcutis Biotherapeutics's Future
October 13, 2023
Via
Benzinga
Where Arcutis Biotherapeutics Stands With Analysts
September 25, 2023
Via
Benzinga
Why Shares of Arcutis Biotherapeutics Fell This Week
September 07, 2023
The company released phase 3 trial results for an atopic dermatitis cream.
Via
The Motley Fool
Earnings Scheduled For November 3, 2023
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
Nasdaq Down Over 1%; Autoliv Raises FY23 Sales Outlook
October 20, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 150 points on Friday. The Dow traded down 0.61% to 33,209.97 while the NASDAQ fell 1.24% to 13,022.16. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 Analysts Have This to Say About Arcutis Biotherapeutics
August 10, 2023
Via
Benzinga
8 Analysts Have This to Say About Arcutis Biotherapeutics
July 18, 2023
Via
Benzinga
Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 20, 2023
Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.
Via
Benzinga
Gold Rises Over 1%; Schlumberger Shares Fall After Q3 Results
October 20, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.31% to 33,309.28 while the NASDAQ fell 1.09% to 13,042.83. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 20, 2023
Via
Benzinga
Analyst Ratings for Arcutis Biotherapeutics
June 28, 2023
Via
Benzinga
Analyst Expectations for Arcutis Biotherapeutics's Future
June 12, 2023
Via
Benzinga
Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
October 20, 2023
Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares surged 95.5% to $0.6226 in pre-market trading after jumping 34% on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
October 20, 2023
We're closing out the trading week with a breakdown of the biggest pre-market stock movers worth watching on Friday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
October 19, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
October 13, 2023
Via
Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Arcutis Biotherapeutics Reveals Promising Data From Lead Drug In Pediatric Patients With Atopic Dermatitis
September 19, 2023
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) announced that the INTEGUMENT-PED Phase 3 trial of roflumilast cream 0.05%, in children ages 2 to 5 years with mild to moderate atopic dermatitis met its...
Via
Benzinga
US Stocks Mostly Higher; RH Posts Upbeat Earnings
September 08, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 60 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 34,491.98 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Biotech Stocks Due for a Massive Short Squeeze
August 31, 2023
These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.
Via
InvestorPlace
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 21, 2023
Via
Benzinga
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
August 19, 2023
Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...
Via
Talk Markets
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
June 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Shares of Arcutis Biotherapeutics Jumped This Week
June 09, 2023
The stock got a push when a British medical journal posted trials information on the company's lead product.
Via
The Motley Fool
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.